Abstract
Stroke is thought to be a multifactorial disease that is affected by several environmental factors and genetic variants. In 2002, a candidate locus for stroke (STRK1) was identified with a significant logarithm of odds (LOD) score at 5q12 in Caucasians, and in 2003, the PDE4D gene was subsequently identified as a susceptibility gene at this locus. Some investigators have recently examined whether polymorphisms in the PDE4D gene are associated with stroke in population studies. Some of these studies have reported the polymorphisms to be associated with a risk of stroke, while others have reported the exact opposite. These discrepancies have been attributed to racial differences or differences in methodologies and analyses. In 2006, a powerful method for isolating the susceptibility region at 5q12 was reported in a haplotype-based case-control study. In the present paper, we review both current issues and progress in the isolation of susceptibility genes for ischemic stroke, with particular emphasis on the PDE4D gene in the STRK1 region of 5q12.
Keywords: Stroke, cerebral infarction, PDE4D gene, case-control study, mutation, polymorphism
Current Medicinal Chemistry
Title: PDE4D Gene in the STRK1 Region on 5q12: Susceptibility Gene for Ischemic Stroke
Volume: 14 Issue: 30
Author(s): Tomohiro Nakayama, Satoshi Asai, Naoyuki Sato and Masayoshi Soma
Affiliation:
Keywords: Stroke, cerebral infarction, PDE4D gene, case-control study, mutation, polymorphism
Abstract: Stroke is thought to be a multifactorial disease that is affected by several environmental factors and genetic variants. In 2002, a candidate locus for stroke (STRK1) was identified with a significant logarithm of odds (LOD) score at 5q12 in Caucasians, and in 2003, the PDE4D gene was subsequently identified as a susceptibility gene at this locus. Some investigators have recently examined whether polymorphisms in the PDE4D gene are associated with stroke in population studies. Some of these studies have reported the polymorphisms to be associated with a risk of stroke, while others have reported the exact opposite. These discrepancies have been attributed to racial differences or differences in methodologies and analyses. In 2006, a powerful method for isolating the susceptibility region at 5q12 was reported in a haplotype-based case-control study. In the present paper, we review both current issues and progress in the isolation of susceptibility genes for ischemic stroke, with particular emphasis on the PDE4D gene in the STRK1 region of 5q12.
Export Options
About this article
Cite this article as:
Nakayama Tomohiro, Asai Satoshi, Sato Naoyuki and Soma Masayoshi, PDE4D Gene in the STRK1 Region on 5q12: Susceptibility Gene for Ischemic Stroke, Current Medicinal Chemistry 2007; 14 (30) . https://dx.doi.org/10.2174/092986707782793871
DOI https://dx.doi.org/10.2174/092986707782793871 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Subject Index To Volume 3
Current Neurovascular Research Optical Imaging of Microvascular Morphology and Perfusion
Current Angiogenesis (Discontinued) Editorial [Hot Topic: Molecular and Clinical Aspects of Hereditary Hemorragic Telangiectasia: A Rare Disease Executive Editor: (Emilo Jirillo)]
Current Pharmaceutical Design Preoperative Functional Magnetic Resonance Imaging (fMRI) and Transcranial Magnetic Stimulation (TMS)
Current Medical Imaging Antiepileptic Drug Monotherapy: The Initial Approach in Epilepsy Management
Current Neuropharmacology A Role for TGF-β Signaling in Neurodegeneration: Evidence from Genetically Engineered Models
Current Alzheimer Research Diagnosis and Management of Heart Failure with Preserved Ejection Fraction: 10 Key Lessons
Current Cardiology Reviews Trefoil Factor Family (TFF) Peptides and their Different Roles in the Mucosal Innate Immune Defense and More: An Update
Current Medicinal Chemistry HspB5/αB-Crystallin: Properties and Current Progress in Neuropathy
Current Neurovascular Research Endovascular Treatment of Pulmonary and Cerebral Arteriovenous Malformations in Patients Affected by Hereditary Haemorrhagic Teleangiectasia
Current Pharmaceutical Design Novel Oral Anticoagulants for Venous Thromboembolism with Special Emphasis on Risk of Hemorrhagic Complications and Reversal Agents
Current Drug Therapy Antiplatelet Therapy And Percutaneous Coronary Interventions
Current Cardiology Reviews A Review on Clinical Management and Pharmacological Therapy on Hereditary Haemorrhagic Telangiectasia (HHT)
Current Vascular Pharmacology Fluorescein Fluorescence Use in the Management of Intracranial Neoplastic and Vascular Lesions: A Review and Report of a New Technique
Current Drug Discovery Technologies A Review of Artificial Intelligence in Cerebrovascular Disease Imaging: Applications and Challenges
Current Neuropharmacology High-output Cardiac Failure: A Forgotten Phenotype in Clinical Practice
Current Cardiology Reviews Heart Transplantation for Congenital Heart Disease in the First Year of Life
Current Cardiology Reviews Cerebroprotective Functions of HO-2
Current Pharmaceutical Design Intracranial Aneurysms; In Need of Early Diagnostic and Treatment Using Bio- and Nanotechnology
Current Medicinal Chemistry Current Status of Renal Arterial Endovascular Interventions
Current Hypertension Reviews